Induction of a specific antibody response to Bordetella pertussis antigens in cultures of human peripheral blood mononuclear cells

Journal of Medical Microbiology

Volumn 48, Issue 12, 1999, Pages 1081-1086

  Giacomini, E ^a   Urbani, F ^a   Ausiello, C M ^a   Luzzati, A L ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; HEMAGGLUTININ; IMMUNOGLOBULIN M; PERTUSSIS TOXIN;

ANTIBODY RESPONSE; ARTICLE; BORDETELLA PERTUSSIS; HUMAN; HUMAN CELL; LYMPHOCYTE; MONONUCLEAR CELL; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0032763377     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-48-12-1081     Document Type: Article

References (31)

1. Cherry JD. Comparative efficacy of acellular pertussis vaccines: An analysis of recent trials. Pediatr Infect Dis J 1997; 16 (4 Suppl): S90 S96.
2. Hewlett EL. Pertussis: Current concepts of pathogenesis and prevention. Pediatr Infect Dis J 1997; 16 (4 Suppl): S78-S84.
3. Pichichcro ME. Pertussis and the pertussis vaccines. Curr Opin Infect Dis 1993; 6: 558-564.
4. Mahon BP, Sheahan BJ, Griffin F, Murphy G, Mills KHG. Atypical disease after Bordetella pertussis respiratory infection of mice with targeted disruptions of Interferon-γ receptor or immunoglobulin μ chain genes. J Exp Med 1997; 186: 1843-1851.
5. Mills KHG, Ryan M, Ryan E, Mahon BP. A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis. Infect Immun 1998; 66: 594-502.
6. Redhead K, Watkins J, Barnard A, Mills KHG. Effective immunization against B. pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity. Infect Immun 1993; 61: 3190-3198.
7. Ausiello CM, Urbani F, la Sala A, Lande R, Cassone A. Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines. Infect Immun 1997; 65: 2168-2174.
8. Cassone A, Ausiello CM, Urbani F et al. Cell-mediated and antibody responses to Bordetella pertussis antigens in children vaccinated with acellular or whole-cell pertussis vaccines. The Progetto Pertosse-CMI Working Group. Arch Pediatr Adolesc Med 1997; 151: 283-289.
9. He Q, Minh NNT, Edelman K, Viljanen MK, Arvilommi H, Mertsola J. Cytokine mRNA expression and proliferative responses induced by pertussis toxin, filamentous hemagglutinin, and pertactin of Bordetella pertussis in the peripheral blood mononuclear cells of infected and immunized school-children and adults. Infect Immun 1998; 66: 3796-3801.
10. Ryan M, Murphy G, Ryan F. et al. Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology 1998; 93: 1-10.
11. Zepp F, Knuf M, Habermehl P et al. Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine. Infect Immun 1996; 64: 4078-4084.
12. Edwards KM, Meade BD, Decker MD et al. Comparison of 13 acellular pertussis vaccines: Overview and serologic response. Pediatrics 1995; 96: 548-557.
13. Greco D, Salmaso S, Mastrantonio P et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N Engl J Med 1996; 334: 341-348
14. Gustafsson L, Hallander HO, Olin P, Reizenstein E, Storsaeter J. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J. Med 1996; 334: 349-355.
15. Miller E, Ashworth I.AE, Redhead R, Thornton C, Waight PA, Coleman T. Effect of schedule on reactogenicity and antibody persistence of acellular and whole-cell pertussis vaccines: Value of laboratory tests as predictors of clinical performance. Vaccine 1997; 15: 51-60.
16. Simondon F, Preziosi M-P, Yam A et al. A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal. Vaccine 1997; 15: 1606-1612.
17. Cherry JD, Gornbein J, Heininger U, Stehr K. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine 1998; 16: 1901-1906.
18. Storsaeter J, Hallander HO, Gustafsson L, Olin P. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 1998; 16: 1907-1916.
19. Giuliano M, Mastrantonio P, Giammanco A, Piscitelli A, Salmaso S, Wassilak SGF. Antibody responses and persistence in the two years following immunization with two acellular and 7 one whole-cell vaccines against pertussis. J Pediatrics 1998; 132: 983-988.
20. Luzzati AL, Giacomini F, Frugoni P, Scuderi G. Central role of IL-2 signal in the induction of a specific antibody response in cultures of normal human peripheral blood lymphocytes. J Immunol Res 1989; 1: 183-189.
21. Giacomini E, Boccanera M, Giordani L., Cassone A, Luzzati AL. Induction of antibody forming cells with specificity for Candida albicans mannoproteins in cultures of human peripheral blood lymphocytes. J Immunol Methods 1993; 164: 203-211.
22. Luzzati AL., Induction of an antibody response in cultures of human peripheral blood lymphocytes. In: Lefkovits I, Pernis B (eds) Immunological Methods, vol II. New York, Academic Press. 1981: 241-246.
23. Sedgwick JD, Holt PG. ELlSA-plaque assay for the detection of single antibody-secreting cells. In: Kemeny DM, Challacombe SJ (eds) ELISA and other Solid Phase Immunoassays. Theoretical and Practical Aspects. Chichester, John Wiley. 1988: 241-263.
24. Ausiello CM, Lande R, la Sala A, Urbani F, Cassone A. Cell-mediated immune response of healthy adults to Bordetella pertusis vaccine antigens. J Infect Dis 1998; 178: 466-470.
25. Zafiropoulos A, Andersson E, Krambovitis E, Borrebaeck CAK. Induction of antigen-specific isotype switching by in vitro immunization of human naive B lymphocytes. J Immunol Methods 1997; 200: 181-190.
26. Gray D. Immunological memory. Annu Rev Immunol 1993; 11: 49-77.
27. Wiertz EJHJ, Loggen HG, Walvoort HC, Kreeftenberg JG. In vitro induction of antigen specific antibody synthesis and proliferation of T lymphocytes with acellular pertussis vaccines, pertussis toxin and filamentous haemagglutinin in humans. J Biol Standard 1989; 17: 181-190.
28. Luzzati AL, Giordani L, Giacomini E. Interleukin-12 up-regulates the induction of an antigen-specific antibody response in cultures of human lymphocytes. Eur J Immunol 1997; 27: 2696-2701.
29. Ryan M, Murphy G, Gothefors L, Nilsson L, Storsaeter J, Mills KHG. Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 T helper cells. J Infect Dis 1997; 175: 1246-1250.
30. Mahon BP, Ryan MS, Griffin F, Mills KHG. Interleukin-12 is produced by macrophages in response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting induction of Th1 cells. Infect Immun 1996; 64: 5295-5301.
31. Ducos J, Bianchi-Mondain A-M, Pageaux G et al. Hepatitis B virus (HBV)-specific in vitro antibody production by peripheral blood mononuclear cells (PBMC) after vaccination by recombinant hepatitis B surface antigen (rHBsAg). Clin Exp Immunol 1996: 103: 15-18.